US trade tribunal to consider new Apple Watch import ban

The U.S. International Trade Commission (ITC) has initiated a new proceeding to determine if Apple's (AAPL.O) redesigned Apple Watches, which reintroduced blood-oxygen measurement technology, still infringe patents held by Masimo (MASI.O), with a decision targeted within six months that could lead to another import ban. This development coincides with a separate jury verdict on Friday, ordering Apple to pay Masimo $634 million in damages for patent infringement, further escalating the multi-front legal dispute between the two companies over medical monitoring technology.

Analysis

The U.S. International Trade Commission (ITC) has initiated a new proceeding to determine if Apple's (AAPL) redesigned Apple Watches, which reintroduced blood-oxygen measurement technology, still infringe Masimo's (MASI) patents. This investigation, targeting a six-month completion, could lead to a renewed import ban on Apple's smartwatches. Concurrently, a jury has ordered Apple to pay Masimo $634 million in damages for patent infringement, underscoring the immediate financial implications for Apple.

This development is part of an escalating, multi-front patent dispute where Masimo alleges Apple stole pulse-oximetry innovations and infringed patents. Apple previously removed the blood-oxygen feature to circumvent an ITC import ban in 2023, only to reintroduce it with U.S. Customs approval, which Masimo is now challenging. The ongoing legal battles highlight significant intellectual property risks within the wearable tech and health monitoring sectors.

The ITC's decision to re-examine the redesigned watches, coupled with the substantial jury award, signals a challenging regulatory and legal environment for Apple's health-focused product strategy. A potential import ban could disrupt Apple Watch supply chains and sales, particularly impacting its premium Series 9 and Ultra 2 models. This situation also sets a precedent for intellectual property enforcement in rapidly evolving technology markets, emphasizing the importance of patent defensibility.

Key Decisions for Investors

• Investors should closely monitor the ITC's six-month investigation outcome and any appeals regarding the $634 million patent infringement verdict, as these could significantly impact Apple Watch sales and profitability.
• Evaluate the potential for renewed import bans on Apple Watches, which could disrupt supply chains and sales volumes, particularly impacting Apple's holiday quarter performance if a ban is reinstated.
• Consider Masimo's strengthened intellectual property position following recent legal victories and the ITC's renewed investigation, potentially enhancing its licensing opportunities or market leverage in medical monitoring technology.